Literature DB >> 18060780

Apolipoprotein epsilon alleles in sporadic inclusion body myositis: a reappraisal.

Merrilee Needham1, Amanda Hooper, Ian James, Frank van Bockxmeer, Alastair Corbett, Timothy Day, Michael J Garlepp, Frank L Mastaglia.   

Abstract

Previous studies have differed as to whether APOE epsilon4 is a susceptibility factor for developing sporadic inclusion body myositis (sIBM), with a positive association being found only in an Australian cohort of cases. We have now re-examined this in a larger cohort of 57 sIBM cases and have also carried out a meta-analysis of all the published studies looking for evidence of a risk association or effect of APOE alleles on disease expression. Our findings argue against a specific role for any APOE alleles in conferring susceptibility to sIBM but have demonstrated a non-significant trend towards an earlier age-of-onset in patients with the epsilon2 allele.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060780     DOI: 10.1016/j.nmd.2007.09.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  7 in total

Review 1.  Apolipoprotein E in Alzheimer's disease and other neurological disorders.

Authors:  Philip B Verghese; Joseph M Castellano; David M Holtzman
Journal:  Lancet Neurol       Date:  2011-03       Impact factor: 44.182

Review 2.  Inclusion body myositis: review of recent literature.

Authors:  Steven A Greenberg
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

3.  The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis.

Authors:  Qiang Gang; Conceicao Bettencourt; Pedro M Machado; Zoe Fox; Stefen Brady; Estelle Healy; Matt Parton; Janice L Holton; David Hilton-Jones; Perry B Shieh; Edmar Zanoteli; Boel De Paepe; Jan De Bleecker; Aziz Shaibani; Michela Ripolone; Raffaella Violano; Maurizio Moggio; Richard J Barohn; Mazen M Dimachkie; Marina Mora; Renato Mantegazza; Simona Zanotti; Michael G Hanna; Henry Houlden
Journal:  Neurobiol Aging       Date:  2015-01-14       Impact factor: 4.673

Review 4.  Genetics in inclusion body myositis.

Authors:  Simon Rothwell; James B Lilleker; Janine A Lamb
Journal:  Curr Opin Rheumatol       Date:  2017-11       Impact factor: 5.006

5.  Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.

Authors:  Simon Rothwell; Robert G Cooper; Ingrid E Lundberg; Peter K Gregersen; Michael G Hanna; Pedro M Machado; Megan K Herbert; Ger J M Pruijn; James B Lilleker; Mark Roberts; John Bowes; Michael F Seldin; Jiri Vencovsky; Katalin Danko; Vidya Limaye; Albert Selva-O'Callaghan; Hazel Platt; Øyvind Molberg; Olivier Benveniste; Timothy R D J Radstake; Andrea Doria; Jan De Bleecker; Boel De Paepe; Christian Gieger; Thomas Meitinger; Juliane Winkelmann; Christopher I Amos; William E Ollier; Leonid Padyukov; Annette T Lee; Janine A Lamb; Hector Chinoy
Journal:  Arthritis Rheumatol       Date:  2017-04-04       Impact factor: 10.995

Review 6.  Ongoing developments in sporadic inclusion body myositis.

Authors:  Pedro M Machado; Mhoriam Ahmed; Stefen Brady; Qiang Gang; Estelle Healy; Jasper M Morrow; Amanda C Wallace; Liz Dewar; Gita Ramdharry; Matthew Parton; Janice L Holton; Henry Houlden; Linda Greensmith; Michael G Hanna
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

Review 7.  Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.

Authors:  Qiang Gang; Conceição Bettencourt; Pedro Machado; Michael G Hanna; Henry Houlden
Journal:  Orphanet J Rare Dis       Date:  2014-06-19       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.